Rentokil Initial (NYSE:RTO) Stock Rating Upgraded by Wall Street Zen

Rentokil Initial (NYSE:RTOGet Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday.

A number of other research firms also recently issued reports on RTO. Bank of America upgraded Rentokil Initial from a “neutral” rating to a “buy” rating and set a $34.00 price target for the company in a research note on Thursday, December 18th. Oppenheimer lifted their price target on shares of Rentokil Initial from $30.00 to $35.00 and gave the company an “outperform” rating in a report on Tuesday, March 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Rentokil Initial in a research report on Thursday, January 22nd. UBS Group upgraded Rentokil Initial from a “neutral” rating to a “buy” rating in a research note on Thursday, March 12th. Finally, Rothschild & Co Redburn raised Rentokil Initial from a “sell” rating to a “neutral” rating in a research note on Wednesday, March 11th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $34.50.

Check Out Our Latest Report on RTO

Rentokil Initial Trading Up 0.0%

Shares of Rentokil Initial stock opened at $30.57 on Friday. The company has a current ratio of 1.12, a quick ratio of 1.03 and a debt-to-equity ratio of 0.79. Rentokil Initial has a 1 year low of $19.60 and a 1 year high of $33.47. The firm’s 50-day moving average is $31.59 and its 200 day moving average is $29.10.

Institutional Investors Weigh In On Rentokil Initial

Large investors have recently added to or reduced their stakes in the stock. Caitong International Asset Management Co. Ltd grew its stake in Rentokil Initial by 222.2% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,163 shares of the company’s stock worth $34,000 after purchasing an additional 802 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Rentokil Initial by 76.5% in the 4th quarter. GAMMA Investing LLC now owns 1,232 shares of the company’s stock valued at $36,000 after acquiring an additional 534 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in Rentokil Initial in the fourth quarter valued at about $39,000. Smartleaf Asset Management LLC boosted its holdings in shares of Rentokil Initial by 171.0% in the 3rd quarter. Smartleaf Asset Management LLC now owns 1,726 shares of the company’s stock valued at $43,000 after buying an additional 1,089 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in shares of Rentokil Initial by 296.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,954 shares of the company’s stock worth $58,000 after buying an additional 1,461 shares during the last quarter. 9.91% of the stock is owned by hedge funds and other institutional investors.

About Rentokil Initial

(Get Free Report)

Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.

Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments.

Further Reading

Analyst Recommendations for Rentokil Initial (NYSE:RTO)

Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.